| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |